Skip to content

Plantar Fasciitis Foot Insole

Effect of Plantar Fasciitis Foot Insole

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01549678
Enrollment
74
Registered
2012-03-09
Start date
2010-08-31
Completion date
2012-08-31
Last updated
2012-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis

Keywords

Plantar fasciitis, foot pain, insoles, foot function, electronic baropodometer, plantar pressure, gait analysis

Brief summary

The hypothesis to be tested is that the use of total contact insoles for six months reduces foot pain, improves function and quality of life of patients diagnosed with plantar fasciitis.

Detailed description

Patients diagnosed with plantar fasciitis, foot pain with VAS between 3 - 8 for walk, over 18 years, regardless of gender who agreed to participate and signing the consent form. Pacietes We excluded patients with other symptomatic lower limb musculoskeletal diseases, diabetes mellitus, rigid deformities in the feet, which made use of insoles, physiotherapy or injections in feet and ankles in the last three months, and previous surgery or planned within the next twelve months.

Interventions

EVA insole shaped on patient´s foot.

EVA insole flat

Sponsors

Fundação de Amparo à Pesquisa do Estado de São Paulo
CollaboratorOTHER_GOV
Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years of age with a diagnosis of PF and foot pain while walking ranging from 3 to 8 points on a 10-point pain scale were analyzed

Exclusion criteria

* Patients with other musculoskeletal conditions in symptomatic lower limbs, inflammatory conditions of the central or peripheral nervous systems, diabetes mellitus or an inability to walk.

Design outcomes

Primary

MeasureTime frameDescription
Visual analog scale of pain in feet during walking (VAS)Six monthsAssessing pain in the feet during walking through a visual analog scale from 0 to 10

Secondary

MeasureTime frameDescription
FHSQ-Br6 monthsFoot Health Status Questionaire
Visual analog scale of pain in feet at reset (VAS)6 monthsAssessing pain in the feet at reset through a visual analog scale from 0 to 10
6-MINUTE WALK TEST6 monthsAssess functional capacity
FFI6 monthsQuestionaire of function of the foot
Likert scale6 monthsLikert scale by patients
Baropodometric tests6 monthsEvaluates charge gistribution in the feet and gait variables
Time use of insole6 monthsControl use of insole
SF-3612 monthsAssess functional capacity

Countries

Brazil

Contacts

Primary ContactHilda Oliveira
hilda_veiga@yahoo.com.br551126910469
Backup ContactJamil MD Natour, PHD
jnatour@unifesp.br551155764239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026